PAYC vs XERS · P/E 33, rev $1.10B vs rev $175.2M
Paycom Soft (PAYC) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Paycom Soft (PAYC) is a software - application company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
PAYC currently screens at market cap $13.06B and trailing P/E 33.1. XERS currently screens at market cap $760.7M.
Not investment advice. Open the PAYC and XERS stock pages for the full models.
Not investment advice.